polycystic ovary syndrome
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for obese polycystic ovary syndrome; 2. Comply with the syndrome differentiation standard of deficiency of kidney yang and mutual congestion of phlegm and blood stasis in TCM; 3. The course of the disease is within 2 years; 4. Patients (gender) between 18 and 35 years old; 5. Patients who have signed an informed consent form. 6. If the subject has used weight loss drugs (such as orlistat, liraglutide, etc.), anti-androgen drugs (Diane-35, spironolactone, etc.), ovulation induction within 1 month before being included in the study Drugs (clomiphene, etc.) can be included in this study after a 3-month drug wash-out period.
Exclusion criteria
Exclusion criteria: 1. Patients with mental illness and severe diseases such as cardiovascular, cerebrovascular, liver, and hematopoietic system; 2. Allergic constitution, or pregnant or lactating women; 3. Patients who participated in other clinical trials within the past 3 months; 4. People with mental illness; 5. Those with contraindications to metformin hydrochloride tablets.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effect of TCM syndromes;Visceral fat area; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subcutaneous fat area;Menstrual condition;laboratory inspection; | — |
Countries
China
Contacts
Longhua Hospital Shanghai University of Traditional Chinese Medicine